日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The nonsteroidal anti-inflammatory drug sulindac reverses obesity-driven immunosuppression and triple-negative breast cancer progression

非甾体抗炎药舒林酸可逆转肥胖引起的免疫抑制和三阴性乳腺癌的进展。

Coleman, Michael F; McDonell, Shannon B; Eisenbeis, Lydia K; Devericks, Emily N; Chandi, Jobin; Dave, Om; Pearce, Jane B; Wang, Sylvia; Cody, Morgan; Bustamante-Marin, Ximena M; Glenny, Elaine M; Rezeli, Erika T; Cozzo, Alyssa J; O'Flanagan, Ciara H; Bathon, Brooke E; Shaikh, Saame Raza; Milne, Ginger L; Wendt, Michael K; Lanman, Nadia A; Teegarden, Dorothy; Hursting, Stephen D

Docosahexaenoic Acid Controls Pulmonary Macrophage Lipid Raft Size and Inflammation.

二十二碳六烯酸控制肺巨噬细胞脂筏大小和炎症

Pennington Edward Ross, Virk Rafia, Bridges Meagan D, Bathon Brooke E, Beatty Nari, Gray Rosemary S, Kelley Patrick, Wassall Stephen R, Manke Jonathan, Armstrong Michael, Reisdorph Nichole, Vanduinen Rachel, Fenton Jenifer I, Gowdy Kymberly M, Shaikh Saame Raza